1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 7,950 | 8,200 | 09:46 | |
| 7,950 | 8,200 | 09:37 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.12.25 | Enhabit, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 11.11.25 | Enhabit auf der UBS Global Healthcare Conference: Strategisches Wachstum trotz Herausforderungen | 1 | Investing.com Deutsch | ||
| 07.11.25 | Enhabit outlines full-year revenue target up to $1.063B while expanding cost controls and payer contracts | 2 | Seeking Alpha | ||
| 06.11.25 | Enhabit reports mixed Q3 results; updates FY25 outlook | 1 | Seeking Alpha | ||
| 05.11.25 | Enhabit, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 05.11.25 | Enhabit, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.09.25 | Enhabit auf Jefferies-Konferenz: Strategische Weichenstellungen angesichts drohender Medicare-Kürzungen | 2 | Investing.com Deutsch | ||
| ENHABIT Aktie jetzt für 0€ handeln | |||||
| 29.09.25 | Enhabit, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.08.25 | Enhabit, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 07.08.25 | Enhabit-Aktie steigt um 15 % nach übertroffenen Gewinnprognosen für Q2 2025 | - | Investing.com Deutsch | ||
| 07.08.25 | Enhabit Q2 2025 slides: Hospice growth offsets Home Health challenges, debt reduction continues | 1 | Investing.com | ||
| 06.08.25 | Enhabit Non-GAAP EPS of $0.13 beats by $0.03, revenue of $266.1M beats by $2.71M | 2 | Seeking Alpha | ||
| 06.08.25 | Enhabit CEO Barb Jacobsmeyer to step down in 2026 | 1 | Investing.com | ||
| 06.08.25 | Enhabit, Inc. - 8-K, Current Report | 3 | SEC Filings |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MCKESSON | 709,20 | +0,25 % | McKesson Builds Earnings Momentum on Specialty and Automation | ||
| TANDEM DIABETES | 19,750 | -2,03 % | TANDEM DIABETES CARE INC - 8-K, Current Report | ||
| LANTHEUS | 58,90 | -1,17 % | Lantheus Holdings, Inc.: Lantheus Announces Closing of SPECT Business Sale to SHINE Technologies | BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians... ► Artikel lesen | |
| COVETRUS | - | - | Covetrus Announces Agreement for Chewy to Acquire SmartEquine | Transaction enables Covetrus to sharpen focus on core business of delivering technology-enabled solutions for veterinarians
PORTLAND, Maine, Oct. 30, 2025 /PRNewswire/... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,300 | +1,33 % | Where Alignment Healthcare Stands With Analysts | ||
| GENEDX | 135,80 | +3,34 % | GeneDx Taps Dr. Linda Genen as Chief Medical Officer | ||
| BRIGHTSPRING HEALTH SERVICES | 40,670 | +3,59 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PACS GROUP | 40,880 | 0,00 % | Morning Market Movers: Mobile-health Network Solutions, PACS Group, Brera Holdings, Cerence See Big Swings | SANTA CLARA (dpa-AFX) - At 7:55 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 34,720 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 26,670 | +0,09 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| ONCOLOGY INSTITUTE | 4,130 | +5,09 % | Oncology Institute, Inc. - 8-K, Current Report | ||
| BILLIONTOONE | 94,93 | -0,39 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| RXSIGHT | 9,990 | -4,58 % | RxSight, Inc. Announces Chief Financial Officer Transition | ALISO VIEJO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,280 | +0,39 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| CERIBELL | 21,730 | 0,00 % | CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection |
ENHABIT INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +1,27 % bei einem Aktienkurs von 7,950 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ENHABIT INC finden Sie auf Wallstreet Online.